Elizabeth Neuman Spar has extensive experience as an attorney, with a focus on intellectual property and patent law, including drafting patent applications, preparing responses to office actions, and contributing to infringement, validity and patentability analyses. With more than 13 years of technical experience in diversified academic research environments, she has drafted patent applications in the fields of molecular and cellular biology, immunology, antibodies, RNAi, biologics, biosimilars, protein expression, genetically transformed plants for use as vaccines and immunogens, genomics, drug discoveries, gene therapy, antitumor therapies, screening assays and protease assays. Dr. Spar's prior positions include post-doctoral fellowships at the Dana Farber Cancer Institute in Boston, and pre-doctoral fellowships at Harvard University. Dr. Spar's awards include the Women's Cancers Program Fellowship, Dana Farber Cancer Institute; and theRyan Fellowship at Harvard University. She received her B.A. in Biology from Oberlin College, her Ph.D. in Cell and Developmental Biology from Harvard University and her J.D. from New England School of Law. Dr. Spar is registered to practice before the U.S. Patent and Trademark Office.
Recent Speaking Engagements and Publications
· "Post-Grant Challenges," co-author, PLI: Fundamentals of Patent Prosecution 2012, May 2012.
· "Successful and Practical Strategies for Patenting Antibodies," speaker, American Conference Institute's 13th Advanced Forum on Biotech Patents, Boston Massachusetts, December 2, 2011.
· "Therapeutic Peptides - Defense Against Generic Encroachment," speaker, TIDES Conference (IBC Life Sciences), Boston, Massachusetts, May 25, 2011.
· "FDA Hears Testimony on Approval Pathway for Biosimilar and Interchangeable Follow-On Biologics," co-author, Edwards Angell Palmer & Dodge Client Advisory, November 2010.
· "Bilski's Impact on Biotechnology and Medical Diagnostic Claims," co-author, Edwards Angell Palmer & Dodge Client Advisory, August 2010.
· "Developing Global Biotech Patent Strategies and Identifying Key Rule Changes in Foreign Patent Offices", speaker, American Conference Institute's (ACI) 11th Advanced Forum on Biotech Patents, Boston, Massachusetts, September 30 - October 1, 2009.
· "Court Ruling May Impact Life Science Patents," co-author, Genetic Engineering & Biotechnology News, February 1, 2009.
· "Patentable Subject Matter: In re Bilski," co-author, Edwards Angell Palmer & Dodge Client Advisory, December 2008.
News & Publications
November 2010, Client Advisory - FDA Hears Testimony on Approval Pathway for Biosimilar and Interchangeable Follow-On Biologics
August 2010, Client Advisory - Bilski's Impact on Biotechnology and Medical Diagnostic Claims
February 1, 2009, Court Ruling May Impact Life Science Patents
Genetic Engineering & Biotechnology News
December 2008, Client Advisory - Patentable Subject Matter: In re Bilski
Events
November 30 - December 2, 2011, Boston, MA, ACI's 13th Advanced Forum on Biotech Patents
May 22 - 25, 2011, Boston, MA, TIDES Conference
September 30 - October 1, 2009, Boston, MA, 11th Advanced Forum on Biotech Patents
Industries
· Life Sciences
Memberships
· WEST, Advisory Board Member